The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-ethyl-5-methyl-N-(4-(piperidin-1-yl)phenethyl)-1H-indole-2-carboxamide ID: ALA5287016
Max Phase: Preclinical
Molecular Formula: C25H31N3O
Molecular Weight: 389.54
Associated Items:
Names and Identifiers Canonical SMILES: CCc1c(C(=O)NCCc2ccc(N3CCCCC3)cc2)[nH]c2ccc(C)cc12
Standard InChI: InChI=1S/C25H31N3O/c1-3-21-22-17-18(2)7-12-23(22)27-24(21)25(29)26-14-13-19-8-10-20(11-9-19)28-15-5-4-6-16-28/h7-12,17,27H,3-6,13-16H2,1-2H3,(H,26,29)
Standard InChI Key: HXOQBWYSGHJGAI-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
-4.7030 -0.2475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9884 0.1647 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2765 -0.2471 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2765 -1.0722 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9867 -1.4840 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.7030 -1.0759 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4918 -1.3272 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.4918 0.0078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0068 -0.6597 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2782 0.8048 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4811 1.0184 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1816 -0.6597 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7690 0.0548 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.7690 -1.3744 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.0561 0.0548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4687 0.7694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2939 0.7694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7067 1.4840 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5294 1.4833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9421 0.7684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5330 0.0565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7082 0.0517 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.4176 0.1651 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7673 0.7684 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.1799 1.4830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0051 1.4830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4176 0.7684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0051 0.0537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1799 0.0537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
4 7 1 0
3 8 1 0
8 9 2 0
9 7 1 0
8 10 1 0
10 11 1 0
9 12 1 0
12 13 1 0
12 14 2 0
13 15 1 0
15 16 1 0
16 17 1 0
18 17 2 0
19 18 1 0
20 19 2 0
21 20 1 0
22 21 2 0
17 22 1 0
1 23 1 0
24 20 1 0
24 25 1 0
26 25 1 0
27 26 1 0
28 27 1 0
24 29 1 0
29 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 389.54Molecular Weight (Monoisotopic): 389.2467AlogP: 5.00#Rotatable Bonds: 6Polar Surface Area: 48.13Molecular Species: NEUTRALHBA: 2HBD: 2#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 5.46CX LogP: 5.51CX LogD: 5.50Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.62Np Likeness Score: -1.07
References 1. Mohamed FAM, Alakilli SYM, El Azab EF, Baawad FAM, Shaaban EIA, Alrub HA, Hendawy O, Gomaa HAM, Bakr AG, Abdelrahman MH, Trembleau L, Mohammed AF, Youssif BGM.. (2023) Discovery of new 5-substituted-indole-2-carboxamides as dual epidermal growth factor receptor (EGFR)/cyclin dependent kinase-2 (CDK2) inhibitors with potent antiproliferative action., 14 (4): [PMID:37122549 ] [10.1039/d3md00038a ]